Mast cell dipeptidyl peptidase I mediates survival from sepsis

Jon Mallen-St Clair1, Christine T N Pham, S Armando Villalta

  • 1Department of Medicine and The Cardiovascular Research Institute, University of California, San Francisco, California 94143-0911, USA.

Insights

Mice lacking dipeptidyl peptidase I (DPPI) show increased survival from sepsis. This survival benefit is linked to mast cell DPPI and higher levels of interleukin-6 (IL-6), suggesting DPPI as a therapeutic target.

Area of Science:

  • Immunology
  • Molecular Biology
  • Pathology

Background:

  • Sepsis is a life-threatening condition with limited therapeutic options.
  • Dipeptidyl peptidase I (DPPI) activates proteases involved in host defense against bacterial infections.

Purpose of the Study:

  • To investigate the role of DPPI in sepsis pathogenesis.
  • To identify DPPI as a potential therapeutic target for sepsis treatment.

Main Methods:

  • Comparison of DPPI knockout (DPPI(-/-)) and wild-type (DPPI(+/+)) mice in a cecal ligation and puncture (CLP) sepsis model.
  • Assessment of survival rates and cytokine levels (IL-6) in peritoneal fluid and serum.
  • In vitro experiments demonstrating IL-6 cleavage by DPPI-activated peptidases.

Main Results:

  • DPPI(-/-) mice exhibited significantly higher survival rates following CLP compared to DPPI(+/+) mice.
  • The survival advantage in DPPI(-/-) mice was attributed to the absence of DPPI specifically in mast cells.
  • Septic DPPI(-/-) mice showed elevated levels of IL-6, and its deletion abolished the survival benefit.
  • DPPI-activated peptidases were shown to cleave IL-6 in vitro.

Conclusions:

  • Mast cell DPPI activity is detrimental to the host during sepsis.
  • Elevated IL-6 levels in DPPI-deficient mice contribute to sepsis survival.
  • DPPI represents a novel therapeutic target for sepsis treatment.

Related Concept Videos

Inflammation01:38

Inflammation

Overview
46.8K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.1K
Acute Inflammation II: Local and Systemic Effects01:25

Acute Inflammation II: Local and Systemic Effects

Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
82
Acute Pancreatitis II: Pathophysiology01:21

Acute Pancreatitis II: Pathophysiology

The pathophysiology of acute pancreatitis centers on injury to pancreatic acinar cells, which initiates a cascade of harmful intracellular events.This injury leads to premature activation of trypsinogen to trypsin in the pancreas. Trypsin then activates other digestive enzymes, such as chymotrypsin, elastase, and phospholipase A2, which begin breaking down pancreatic tissue. The resulting autodigestion causes local inflammation, tissue swelling, hemorrhage, and fat necrosis.Injured acinar cells...
49